...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Nonprofit Think Tank
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Would be possible except for a lot of other persons (BoD, eg.) would have to be complicit in this scheme also for it to work for him.

5 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply